The Board of Directors of the Company, at their Board Meeting held today i.e. 15 May 2026, inter-alia, approved and noted the following business(es): 1. Approval of the Audited Financial ....
MPSLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.1 pts more than Nifty Microcap 250 and 7.6 pts more than its Printing & Publication peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
MPS Limited reported audited standalone results for FY2026 with total income of INR 38,125 lakhs (up 14.4% from INR 33,336 lakhs in FY2025) and profit after tax of INR 13,126 lakhs (up 18% from INR 11,116 lakhs). EPS stood at INR 64.86. The Board decided against recommending a final dividend for FY2025-26, citing cash deployment towards the acquisition of Unbound Medicine, Inc. completed on 9 February 2026. The company appointed KPMG as internal auditors for 3 years and re-appointed Walker Chandiok & Co LLP as statutory auditors for another 5-year term. Statutory auditors issued an unmodified opinion on both standalone and consolidated financial results.
The absence of a dividend may disappoint short-term investors expecting returns, though the company is prioritizing growth investments. Strong revenue and profit growth with a clean audit opinion are positive signals for long-term shareholders.